[MCEMENT] YoY Cumulative Quarter Result on 31-Dec-2005 [#4]

Stock
[MCEMENT] MALAYAN CEMENT BERHAD
Announcement Date
23-Feb-2006
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2005
Quarter
31-Dec-2005 [#4]
Profit Trend
QoQ- 497.97%
YoY- -64.01%
Quarter Report
Latest QR
Upcoming QR
MCEMENT's Result
MCEMENT's Financial Summary
View:
Show?
Cumulative Result
31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 CAGR
Revenue 2,530,771 2,173,532 2,077,893 1,866,668 1,761,555 1,747,997 1,674,005 7.12%
PBT 397,772 318,134 211,968 29,345 103,693 156,210 101,495 25.53%
Tax -31,554 -33,443 -38,635 1,956 -20,918 -37,234 -18,110 9.68%
NP 366,218 284,691 173,333 31,301 82,775 118,976 83,385 27.94%
-
NP to SH 367,684 288,147 174,661 29,792 82,775 118,976 83,385 28.02%
-
Tax Rate 7.93% 10.51% 18.23% -6.67% 20.17% 23.84% 17.84% -
Total Cost 2,164,553 1,888,841 1,904,560 1,835,367 1,678,780 1,629,021 1,590,620 5.26%
-
Net Worth 3,031,482 4,224,840 3,297,814 3,306,912 1,998,017 2,026,355 2,026,718 6.93%
Dividend
31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 CAGR
Div 254,746 247,066 84,559 59,584 78,493 57,895 43,429 34.25%
Div Payout % 69.28% 85.74% 48.41% 200.00% 94.83% 48.66% 52.08% -
Equity
31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 CAGR
Net Worth 3,031,482 4,224,840 3,297,814 3,306,912 1,998,017 2,026,355 2,026,718 6.93%
NOSH 849,154 856,359 2,818,645 2,979,200 2,854,310 2,894,793 2,895,312 -18.47%
Ratio Analysis
31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 CAGR
NP Margin 14.47% 13.10% 8.34% 1.68% 4.70% 6.81% 4.98% -
ROE 12.13% 6.82% 5.30% 0.90% 4.14% 5.87% 4.11% -
Per Share
31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 CAGR
RPS 298.03 175.95 73.72 62.66 61.72 60.38 57.82 31.39%
EPS 43.30 21.00 12.30 1.00 2.90 4.11 2.88 57.03%
DPS 30.00 20.00 3.00 2.00 2.75 2.00 1.50 64.67%
NAPS 3.57 3.42 1.17 1.11 0.70 0.70 0.70 31.16%
Adjusted Per Share Value based on latest NOSH - 2,867,538
31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 CAGR
RPS 189.87 163.07 155.89 140.05 132.16 131.14 125.59 7.12%
EPS 27.59 21.62 13.10 2.24 6.21 8.93 6.26 28.01%
DPS 19.11 18.54 6.34 4.47 5.89 4.34 3.26 34.24%
NAPS 2.2743 3.1697 2.4742 2.481 1.499 1.5203 1.5205 6.93%
Price Multiplier on Financial Quarter End Date
31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 CAGR
Date 31/12/08 31/12/07 29/12/06 30/12/05 31/12/04 31/12/03 31/12/02 -
Price 3.94 5.85 4.60 2.05 2.43 3.00 2.57 -
P/RPS 1.32 3.32 6.24 3.27 3.94 4.97 4.45 -18.31%
P/EPS 9.10 25.08 74.23 205.00 83.79 72.99 89.24 -31.62%
EY 10.99 3.99 1.35 0.49 1.19 1.37 1.12 46.26%
DY 7.61 3.42 0.65 0.98 1.13 0.67 0.58 53.51%
P/NAPS 1.10 1.71 3.93 1.85 3.47 4.29 3.67 -18.17%
Price Multiplier on Announcement Date
31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 CAGR
Date 18/02/09 27/02/08 16/02/07 23/02/06 28/02/05 24/02/04 28/02/03 -
Price 3.86 5.60 5.67 2.52 2.77 3.53 2.42 -
P/RPS 1.30 3.18 7.69 4.02 4.49 5.85 4.19 -17.70%
P/EPS 8.91 24.01 91.50 252.00 95.52 85.89 84.03 -31.17%
EY 11.22 4.17 1.09 0.40 1.05 1.16 1.19 45.29%
DY 7.77 3.57 0.53 0.79 0.99 0.57 0.62 52.34%
P/NAPS 1.08 1.64 4.85 2.27 3.96 5.04 3.46 -17.62%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment